Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model
2008 - Kanold J,Paillard C,Tchirkov A,Merlin E,Marabelle A,Lutz P,Rousseau R,Baldomero H,Demeocq F Bone Marrow Transplant n°42(sup 2) - pp 25-30
Association between genetic polymorphisms and ovarian cancer risk
2008 - Delort L,Chalabi N,Satih S,Rabiau N,Kwiatkowski F,Bignon YJ,Bernard-Gallon DJ Anticancer Res n°28 (5B) - pp 3079-81
Axillary recurrence after negative sentinel lymph node biopsy in breast cancer
2008 - Le-Bouedec G,Gauthier T,Gimbergues P,Dauplat J Presse Med n°37 - pp 1685-92
BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases
2008 - Uhrhammer N,Abdelouahab A,Lafarge L,Feillel V,Ben-Dib A,Bignon YJ Int J Med Sci n°5 - pp 197-202
Capillary permeability and extracellular volume fraction in uterine cervical cancer as patient outcome predictor : measurements by using dynamic MRI spin-lattice relaxometry
2008 - Dedieu V,Bailly C,Vincent C,Achard JL,Le-Bouedec G,Penault-Llorca F,Verrelle P,Vincensini D J Magn Reson Imaging n°27 - pp 846-853
Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy
2008 - Penault-Llorca F,Abrial C,Raoelfils I,Chollet P,Cayre A,Mouret-Reynier MA,Thivat E,Mishellany F,Gimbergues P,Durando X The Oncologist n°13 - pp 1235-45
Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences
2008 - Chalabi N,Bernard-Gallon DJ,Bignon YJ,Kwiatkowski F,Agier M,Vidal V,Laplace-Chabaud V,Sylvain-Vidal V,Bertholet V,De-Longueville F,Lacroix M,Leclercq G,Remacle J,Sibille C,Zammateo N,Ben-Jaafar N,Sefiani A,Ouldim K,Megarbane K,Jalkh N,Mahfoudh W,Troudi W,Ben-Ammar-El-Gaied A,Chouchane L Cancer Genomics Proteomics n°5 - pp 253-61
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer
2008 - Penault-Llorca F,Abrial C,Raoelfils I,Cayre A,Mouret-Reynier MA,LeHeurteur M,Durando X,Achard JL,Gimbergues P,Chollet P Hum Pathol n°39 - pp 1221-8
Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer
2008 - Troudi W,Uhrhammer N,Romdhane KB,Sibille C,Amor MB,Khodjet-El-Khil H,Jalabert T,Mahfoudh W,Chouchane L,Ayed FB,Bignon YJ,Elgaaied AB cancer Biomark n°4 - pp 11-8
Detection of KRAS mutations: evolution or revolution for the pathologists?
2008 - Bideau F,Penault-Llorca F,Sabourin JC Ann Pathol n°28 - pp 261-2
Development of automated BDISH application for HER2 gene and chromosome CEN 17 for breast carcinomas and an assay performance comparison to manual dual color HER2 FISH
2008 - Nitta H,Hauss-Wegrzyniak B,Lehrkamp M,Murillo AE,Gaire F,Farrell M,Walk E,Penault-Llorca F,Kurosumi M,Dietel M,Wang L,Loftus M,Pettay J,Tubbs RR,Grogan TM Diagn Pathol n°3 - pp 41
DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
2008 - Bernard-Gallon DJ,Bosviel R,Delort L,Fontana L,Chamoux A,Rabiau N,Kwiatkowski F,Chalabi N,Satih S,Bignon YJ Mol Cancer n°7 - pp 36
DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort
2008 - Fontana L,Bosviel R,Delort L,Guy L,Chalabi N,Kwiatkowski F,Satih S,Rabiau N,Boiteux JP,Chamoux A,Bignon YJ,Bernard-Gallon DJ Anticancer Res n°28(3B) - pp 1853-6
Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy
2008 - Loriot Y,Perlemuter G,Malka D,Penault-Llorca F,Boige V,Deutsch E,Massard C,Armand JP,Soria JC Nat Clin Pract Oncol n°5 - pp 268-78
Essentials of molecular biology in cancer research
2008 - Rangel MC,Da-Silva SD,Pereira NC,Dominguez MV Applied Cancer Research n°28 - pp 2-10
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis
2008 - Andre F,Broglio K,Roche H,Martin M,Mackey JR,Penault-Llorca F,Hortobagyi GN,Pusztai L J Clin Oncol n°26 - pp 2636-43
Familial delection 11q14.3-q22.1 without apparent phenotypic consequences : a haplosufficient 8.5 Mb region
2008 - Goumy C,Gouas L,Tchirkov A,Roucaute T,Giollant M,Veronese L,Francannet C,Vago P Am J Med Genet A n°146(A) - pp 2668-72
Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs
2008 - Tabone-Elinger S,Bahleda R,Cote JF,Terrier P,Vidaud D,Cayre A,Beauchet A,Theou-Anton N,Terrier-Lacombe MJ,Lemoine A,Penault-Llorca F,Le-Cesne A,Emile JF Sarcoma n°2008 - pp 849156
Functional outcome and quality of life after pancreaticoduodenectomy
2008 - Le-Page S,Caputo S,Kwiatkowski F,Berard P,Gouillat C J Chir n°145 - pp 32-6
Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities
2008 - Gouas L,Goumy C,Veronese L,Tchirkov A,Vago P Pathol Biol n°56 - pp 345-53